These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 20448485)

  • 41. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.
    Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V
    Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neurofibrillary changes undergoing morphological and biochemical changes - How does tau with the profile shift of from four repeat to three repeat spread in Alzheimer brain?
    Uchihara T
    Neuropathology; 2020 Oct; 40(5):450-459. PubMed ID: 32698244
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The neuropathological spectrum of neurodegenerative tauopathies.
    Tolnay M; Probst A
    IUBMB Life; 2003 Jun; 55(6):299-305. PubMed ID: 12938731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease.
    Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ
    Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
    Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
    Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ultrasensitive and selective detection of 3-repeat tau seeding activity in Pick disease brain and cerebrospinal fluid.
    Saijo E; Ghetti B; Zanusso G; Oblak A; Furman JL; Diamond MI; Kraus A; Caughey B
    Acta Neuropathol; 2017 May; 133(5):751-765. PubMed ID: 28293793
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calpain activation in neurodegenerative diseases: confocal immunofluorescence study with antibodies specifically recognizing the active form of calpain 2.
    Adamec E; Mohan P; Vonsattel JP; Nixon RA
    Acta Neuropathol; 2002 Jul; 104(1):92-104. PubMed ID: 12070670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease.
    Camacho J; Rábano A; Marazuela P; Bonaterra-Pastra A; Serna G; Moliné T; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M
    Brain Pathol; 2022 Jan; 32(1):e13016. PubMed ID: 34514662
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Selective tau tyrosine nitration in non-AD tauopathies.
    Reyes JF; Geula C; Vana L; Binder LI
    Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
    Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
    J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ultrastructural characteristics of tau filaments in tauopathies: immuno-electron microscopic demonstration of tau filaments in tauopathies.
    Arima K
    Neuropathology; 2006 Oct; 26(5):475-83. PubMed ID: 17080728
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lateral geniculate body is spared of tau pathology in Pick disease.
    Chang K; Barrett A; Pham K; Troncoso JC
    J Neuropathol Exp Neurol; 2024 Mar; 83(4):238-244. PubMed ID: 38412343
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tau immunoreactivity in peripheral tissues of human aging and select tauopathies.
    Dugger BN; Hoffman BR; Scroggins A; Serrano GE; Adler CH; Shill HA; Belden CM; Sabbagh MN; Caviness JN; Driver Dunckley E; Beach TG
    Neurosci Lett; 2019 Mar; 696():132-139. PubMed ID: 30579993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tangle evolution linked to differential 3- and 4-repeat tau isoform deposition: a double immunofluorolabeling study using two monoclonal antibodies.
    Uchihara T; Hara M; Nakamura A; Hirokawa K
    Histochem Cell Biol; 2012 Feb; 137(2):261-7. PubMed ID: 22116524
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of phosphorylation site of tau protein with neuronal apoptosis in Alzheimer's disease.
    Kobayashi K; Nakano H; Hayashi M; Shimazaki M; Fukutani Y; Sasaki K; Sugimori K; Koshino Y
    J Neurol Sci; 2003 Apr; 208(1-2):17-24. PubMed ID: 12639720
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deep learning-based model for diagnosing Alzheimer's disease and tauopathies.
    Koga S; Ikeda A; Dickson DW
    Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12759. PubMed ID: 34402107
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies.
    Fiock KL; Betters RK; Hefti MM
    J Histochem Cytochem; 2023 Feb; 71(2):73-86. PubMed ID: 36861683
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Anatomic survey of seeding in Alzheimer's disease brains reveals unexpected patterns.
    Stopschinski BE; Del Tredici K; Estill-Terpack SJ; Ghebremedhin E; Yu FF; Braak H; Diamond MI
    Acta Neuropathol Commun; 2021 Oct; 9(1):164. PubMed ID: 34635189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correspondence regarding: selective deposition of 4-repeat tau in cerebral infarcts. J Neuropathol Exp Neurol 2009;68:1029-36.
    Kasahata N; Miyazawa Y; Kamei T
    J Neuropathol Exp Neurol; 2010 Mar; 69(3):321; author reply 321. PubMed ID: 20190609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.